Timrepigene emparvovec Completed Phase 2 Trials for Choroideremia Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02407678 | REP1 Gene Replacement Therapy for Choroideremia | |
| NCT02553135 | Choroideremia Gene Therapy Clinical Trial | |
| NCT03507686 | A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 |